GPT-Rosalind is OpenAI's first domain-specific model, built for drug discovery and life sciences—and it's not for everyone.
CoreWeave posted FY25 revenue of $5.1B and a $66.8B backlog but remains unprofitable and highly leveraged. Read why CRWV ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results